Matches in SemOpenAlex for { <https://semopenalex.org/work/W2590609475> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2590609475 endingPage "5079" @default.
- W2590609475 startingPage "5079" @default.
- W2590609475 abstract "5079 Background: There is limited data on the role of neoadjuvant chemotherapy (NACT) in advanced malignant ovarian germ cell tumors (MOGCT).We attempted NACT in 20 Pts of advanced MOGCT who were considered high risk for surgery (very poor general health; ECOG performance status, 3-4) in order to preserve fertility. Methods: Between 1988 and December 2009, 20 of 211 patients with MOGCT were considered unsuitable for exploratory laparotomy because of their high risk status. Pts median age was 19 yrs, ranging from 14-28 yrs. All had stage III (n=17) or IV (n=3) disease. Diagnosis was confirmed by FNAC /Biopsy & baseline tumor marker levels. 11 pts had dysgerminoma, 6 had mixed subtype & 3 had endodermal sinus tumor (EST). All were planned for four cycles of BEP chemotherapy followed by fertility sparing surgery (U/L salpingo-oophorectomy + omentectomy ± Lymphadenectomy). Results: 18 Pts were evaluable for treatment response & outcome. One Pt died after 1st cycle of CT due to progressive disease and another Pt was lost to FU after 2 cycles. Post 4 cycles of chemotherapy, 18 responded: CR-13, PR-5. 15 Pts underwent surgery with pathological CR in 13/15 (86.6%); 2 Pts had residual disease, both of them achieved CR following 2 cycles of salvage chemotherapy. Remaining three Pts refused for surgery; 2 out of 3 relapsed at 9 and 12 months, both achieved CR with salvage chemotherapy and subsequent fertility sparing surgery; third Pt continues to be alive and in good health. Currently 18 of 20 patients are alive and disease free and in one status is unknown at a median follow-up of 48 months (range: 12-96 months). All of them have resumed menstruation and 3 eligible Pts have delivered full term healthy babies. Conclusions: NACT followed by fertility sparing surgery is an effective treatment strategy for patients of advanced MOGCT who are high risk candidates for surgery." @default.
- W2590609475 created "2017-03-03" @default.
- W2590609475 creator A5016541448 @default.
- W2590609475 creator A5017359031 @default.
- W2590609475 creator A5029461350 @default.
- W2590609475 creator A5043150287 @default.
- W2590609475 creator A5048147516 @default.
- W2590609475 creator A5055044953 @default.
- W2590609475 creator A5063703561 @default.
- W2590609475 creator A5080356351 @default.
- W2590609475 date "2011-05-20" @default.
- W2590609475 modified "2023-10-14" @default.
- W2590609475 title "Is there a place for neoadjuvant chemotherapy in the management of advanced malignant germ cell tumors of ovary?" @default.
- W2590609475 doi "https://doi.org/10.1200/jco.2011.29.15_suppl.5079" @default.
- W2590609475 hasPublicationYear "2011" @default.
- W2590609475 type Work @default.
- W2590609475 sameAs 2590609475 @default.
- W2590609475 citedByCount "0" @default.
- W2590609475 crossrefType "journal-article" @default.
- W2590609475 hasAuthorship W2590609475A5016541448 @default.
- W2590609475 hasAuthorship W2590609475A5017359031 @default.
- W2590609475 hasAuthorship W2590609475A5029461350 @default.
- W2590609475 hasAuthorship W2590609475A5043150287 @default.
- W2590609475 hasAuthorship W2590609475A5048147516 @default.
- W2590609475 hasAuthorship W2590609475A5055044953 @default.
- W2590609475 hasAuthorship W2590609475A5063703561 @default.
- W2590609475 hasAuthorship W2590609475A5080356351 @default.
- W2590609475 hasConcept C121608353 @default.
- W2590609475 hasConcept C126322002 @default.
- W2590609475 hasConcept C141071460 @default.
- W2590609475 hasConcept C2776694085 @default.
- W2590609475 hasConcept C2776938808 @default.
- W2590609475 hasConcept C2777904497 @default.
- W2590609475 hasConcept C2778822529 @default.
- W2590609475 hasConcept C2778966966 @default.
- W2590609475 hasConcept C2780824555 @default.
- W2590609475 hasConcept C2908647359 @default.
- W2590609475 hasConcept C518429986 @default.
- W2590609475 hasConcept C71924100 @default.
- W2590609475 hasConcept C99454951 @default.
- W2590609475 hasConceptScore W2590609475C121608353 @default.
- W2590609475 hasConceptScore W2590609475C126322002 @default.
- W2590609475 hasConceptScore W2590609475C141071460 @default.
- W2590609475 hasConceptScore W2590609475C2776694085 @default.
- W2590609475 hasConceptScore W2590609475C2776938808 @default.
- W2590609475 hasConceptScore W2590609475C2777904497 @default.
- W2590609475 hasConceptScore W2590609475C2778822529 @default.
- W2590609475 hasConceptScore W2590609475C2778966966 @default.
- W2590609475 hasConceptScore W2590609475C2780824555 @default.
- W2590609475 hasConceptScore W2590609475C2908647359 @default.
- W2590609475 hasConceptScore W2590609475C518429986 @default.
- W2590609475 hasConceptScore W2590609475C71924100 @default.
- W2590609475 hasConceptScore W2590609475C99454951 @default.
- W2590609475 hasIssue "15_suppl" @default.
- W2590609475 hasLocation W25906094751 @default.
- W2590609475 hasOpenAccess W2590609475 @default.
- W2590609475 hasPrimaryLocation W25906094751 @default.
- W2590609475 hasRelatedWork W1901841823 @default.
- W2590609475 hasRelatedWork W1980324865 @default.
- W2590609475 hasRelatedWork W1987013390 @default.
- W2590609475 hasRelatedWork W1988141960 @default.
- W2590609475 hasRelatedWork W2081872483 @default.
- W2590609475 hasRelatedWork W2088035700 @default.
- W2590609475 hasRelatedWork W2161276519 @default.
- W2590609475 hasRelatedWork W2405564588 @default.
- W2590609475 hasRelatedWork W2993062244 @default.
- W2590609475 hasRelatedWork W2184632057 @default.
- W2590609475 hasVolume "29" @default.
- W2590609475 isParatext "false" @default.
- W2590609475 isRetracted "false" @default.
- W2590609475 magId "2590609475" @default.
- W2590609475 workType "article" @default.